Avda. de la Plata, 20
46013 Valencia
Teléfono: 963355110
Fax: 963348702
 
 
Artículos recomendados en 2011

Referencias a artículos incluidos en PubMed que los socios consideren de especial interés. Si deseas colaborar, envía la referencia recomendada, indicando tu nombre y centro de trabajo, a la siguiente dirección de correo electrónico:

  • Breynaert C, Ferrante M, Fidder H, Van Steen K, Noman M, Ballet V, Vermeire S, Rutgeerts P, Van Assche G. Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study. Am J Gastroenterol. 2011 Apr;106(4):778-85.  [PubMed]
    [12-6-2011. José Joaquín Ramírez. Hospital Lluis Alcanyis, Xàtiva]

  • Yanai H, Hanauer SB. Assessing response and loss of response to biological therapies in IBD. Am J Gastroenterol. 2011 Apr;106(4):685-98.  [PubMed]
    [3-4-2011. José Joaquín Ramírez. Hospital Lluis Alcanyis, Xàtiva]

  • Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Mar;33(6):619-33.  [PubMed]
    [24-3-2011. José Joaquín Ramírez. Hospital Lluis Alcanyis, Xàtiva]

  • Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2011 Mar 15. [Epub ahead of print].  [PubMed]
    [24-3-2011. José Joaquín Ramírez. Hospital Lluis Alcanyis, Xàtiva]

  • Lanas A, Calvet X, Feu F, Ponce J, Gisbert JP, Barkun A; en representación del Consenso sobre Hemorragia Digestiva por Úlcera Péptica. Primer consenso español sobre el tratamiento de la hemorragia digestiva por úlcera péptica. Med Clin (Barc). 2010 Nov 6;135(13):608-16.  [PubMed]
    [24-3-2011. José Joaquín Ramírez. Hospital Lluis Alcanyis, Xàtiva]

  • Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG. Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis. Hepatology. 2011 May;53(5):1590-9.  [PubMed]
    [9-5-2011. Joaquín Primo. Hospital de Sagunto]

  • Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, Roulot D, Mallat A, Hillaire S, Cales P, Ollivier I, Vinel JP, Mathurin P, Bronowicki JP, Vilgrain V, N'kontchou G, Beaugrand M, Chevret S; for the Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH). Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities. Hepatology. 2011 Dec;54(6):1987-1997.  [PubMed]
    [11-12-2011. Joaquín Primo. Hospital de Sagunto]

  • Cacoub P, Bourlière M, Lübbe J, Dupin N, Buggisch P, Dusheiko G, Hézode C, Picard O, Pujol R, Segaert S, Thio B, Roujeau JC. Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals. J Hepatol. 2012 Feb;56(2):455-63.  [PubMed]  
    [19-10-2011. Joaquín Primo. Hospital de Sagunto]

  • Sherman KE, Flamm SL, Afdhal NH, Nelson DR, Sulkowski MS, Everson GT, Fried MW, Adler M, Reesink HW, Martin M, Sankoh AJ, Adda N, Kauffman RS, George S, Wright CI, Poordad F; ILLUMINATE Study Team. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med. 2011 Sep 15;365(11):1014-24.  [PubMed]
    [16-9-2011. Joaquín Primo. Hospital de Sagunto]

  • Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S; ADVANCE Study Team. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011 Jun 23;364(25):2405-16.  [PubMed]  
    [24-6-2011. Joaquín Primo. Hospital de Sagunto]

  • Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P, Nevens F, Müllhaupt B, Pockros P, Terg R, Shouval D, van Hoek B, Weiland O, Van Heeswijk R, De Meyer S, Luo D, Boogaerts G, Polo R, Picchio G, Beumont M; REALIZE Study Team. Telaprevir for retreatment of HCV infection. N Engl J Med. 2011 Jun 23;364(25):2417-28.  [PubMed]  
    [24-6-2011. Joaquín Primo. Hospital de Sagunto]

  • Zoutendijk R, Reijnders JG, Brown A, Zoulim F, Mutimer D, Deterding K, Petersen J, Hofmann WP, Buti M, Santantonio T, van Bömmel F, Pradat P, Oo Y, Luetgehetmann M, Berg T, Hansen BE, Wedemeyer H, Janssen HL; for the VIRGIL Surveillance Study Group. Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response. Hepatology. 2011 May 11. doi: 10.1002/hep.24406. [Epub ahead of print].  [PubMed]
    [28-5-2011. Joaquín Primo. Hospital de Sagunto]

  • Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. J Hepatol. 2011 Jun;54(6):1250-62.  [PubMed]  
    [26-5-2011. Joaquín Primo. Hospital de Sagunto]

  • Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J; on behalf of the FRESGUN. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol. 2011 May;54(5):1011-1019.  [PubMed]
    [9-5-2011. Joaquín Primo. Hospital de Sagunto]

  • Freedman ND, Curto TM, Lindsay KL, Wright EC, Sinha R, Everhart JE; HALT-C Trial Group. Coffee Consumption is Associated with Response to Peginterferon and Ribavirin Therapy in Patients with Chronic Hepatitis C. Gastroenterology. 2011 Mar 1. [Epub ahead of print].  [PubMed]
    [17-4-2011. Salvador Benlloch. Hospital General Universitario de Valencia]

  • Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011 May;54(5):1030-40.  [PubMed]  
    [17-4-2011. Joaquín Primo. Hospital de Sagunto]

  • Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011 Apr;140(4):1189-98.  [PubMed]
    [4-4-2011. Joaquín Primo. Hospital de Sagunto]

  • Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011 May;60(5):702-9.  [PubMed]
    [4-4-2011. Joaquín Primo. Hospital de Sagunto]

  • Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. J Hepatol. 2011 Apr;54(4):650-9.  [PubMed]
    [4-4-2011. Joaquín Primo. Hospital de Sagunto]

  • Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM,Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP; SPRINT-2 Investigators. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011 Mar 31;364(13):1195-206.  [PubMed]  
    [3-4-2011. Joaquín Primo. Hospital de Sagunto]

  • Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R; HCV RESPOND-2 Investigators. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011 Mar 31;364(13):1207-17.  [PubMed]  
    [3-4-2011. Joaquín Primo. Hospital de Sagunto]

 
   
 
| Inicio | Historia | Junta Directiva | Estatutos | Reglamento | Socios | Grupos de trabajo | Actividades | Enlaces |